Ascendis Pharma Announces Timing of Third Quarter 2023 Financial Results and TransCon PTH NDA Resubmission
Source:
Nasdaq GlobeNewswire
/
31 Oct 2023 07:30:00 America/Chicago
N/A
Share on,